SCHEMBL1225854

SCHEMBL1225854

OC1CCC(Nc2cc(-c3cccc(NC4CCNCC4)n3)c(Cl)cn2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1192115 1.00 CCNT1 (1.00) CCNT1
SCHEMBL12889514 0.89 CCNT1 (1.00) CCNT1
SCHEMBL12898165 0.89 CCNT1 (0.80) CCNT1
SCHEMBL12889685 0.87 CCNT1 (1.00) CCNT1
SCHEMBL1225590 0.84 CCNT1 (0.72) CCNT1
SCHEMBL1192199 0.84 CCNT1 (0.72) CCNT1
SCHEMBL12850632 0.82 CCNT1 (1.00) CCNT1
SCHEMBL12850628 0.82 CCNT1 (1.00) CCNT1
SCHEMBL12889599 0.82 CCNT1 (1.00) CCNT1
SCHEMBL12889758 0.82 CCNT1 (1.00) CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2459535-A1 PYRIDINE AND PYRAZINE DERIVATIVES AS PROTEIN KINASE MODULATORS Novartis AG (CH) 2012-06-06 EP disclosed
WO-2011012661-A1 PYRIDINE AND PYRAZINE DERIVATIVES AS PROTEIN KINASE MODULATORS NOVARTIS AG (CH) 2011-02-03 WO disclosed